Merck & Co beat quarterly earnings estimates as sales of blockbuster drug Keytruda nearly doubled, but investors were disappointed after the drugmaker said it was unlikely to follow rival Eli Lilly in separating its animal health unit.
Source:: Reuters – Business News
